Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. - sprookjes - yvandenbroek - TriplyDB

Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.

Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.

http://www.wikidata.org/entity/Q35800552

about

Virtual Raters for Reproducible and Objective Assessments in Radiology Serum YKL-40 following resection for cerebral glioblastoma Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR)A novel method for volumetric MRI response assessment of enhancing brain tumors A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients Response criteria for glioma.Resources Required for Semi-Automatic Volumetric Measurements in Metastatic Chordoma: Is Potentially Improved Tumor Burden Assessment Worth the Time Burden?Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST The role of advanced MR imaging in understanding brain tumour pathology.Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.Impact of MRI head placement on glioma response assessment.A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume.Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.Revisiting the relationship between tumour volume and diameter in advanced NSCLC patients: An exercise to maximize the utility of each measure to assess response to therapy Prediction of glioblastoma multiform response to bevacizumab treatment using multi-parametric MRI.Conventional MRI evaluation of gliomas.Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.Multicentre imaging measurements for oncology and in the brain.Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement.Assessment of objective responses using volumetric evaluation in advanced thymic malignancies and metastatic non-small cell lung cancer.Evaluation of early imaging response criteria in glioblastoma multiforme.Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria.Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery Progressive disease in glioblastoma: Benefits and limitations of semi-automated volumetry.Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Activity in Human Glioma Samples Predicts Tumor Presence and Clinical Prognosis.Unidimensional Measurement May Evaluate Target Lymph Nodal Response After Induction Chemotherapy for Nasopharyngeal Carcinoma.Clinical Evaluation of a Fully-automatic Segmentation Method for Longitudinal Brain Tumor Volumetry.Inhibiting kinases in malignant gliomas.Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study.Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study Brain tumor imaging in clinical trials.Comparison of two-dimensional and three-dimensional iterative watershed segmentation methods in hepatic tumor volumetrics Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model.Clinical trial end points for high-grade glioma: the evolving landscape.Volumetric response evaluation after intensity modulated radiotherapy in patients with supratentorial gliomas.Assessment of Brain Tumor Response: RANO and Its Offspring.

P2860

Q27318743-5711A51C-6552-4B3C-A802-76954DED8520 Q28253544-8E7F26EA-E5F8-4DEF-8552-E8D465BD57A1 Q28651176-1C619309-9650-4C88-8045-F2B79A518A6B Q28743259-038B7754-EDB7-42A3-9822-959C3B53B4F1 Q30408669-E0D4D176-BFC7-4E42-A9EB-D9DD0CBE5F8F Q30437854-B3833286-CF0B-47E4-8241-7456A190FFCA Q30607148-939EBF3D-2541-444C-8F9C-E17B5A7F3929 Q30692995-FB8E01A1-9C28-4E3F-A47F-EB8D4E4351C4 Q31172444-6763EB58-BFCC-4B2E-9632-B71AFF0CA60E Q33275815-59F45DA6-14C3-47B7-BC63-81511D9BC64C Q33276181-EA57FFE3-D949-42C2-9CE6-65685E58D60A Q33309683-F53969A8-43D5-4C59-A4FC-F05F1B2B0513 Q33586021-8EFB8A32-F10A-4459-8735-C08520E60772 Q33632237-96161859-A625-4449-8F5B-AD62263E556C Q33874889-5E1CD040-DA5E-4A20-ACFA-4995A297C5B4 Q33905155-37AE8484-57BB-4199-BB7A-3407950C2A27 Q33929944-BFC74D85-CBCB-4844-A32E-F4E77B1EA350 Q34130827-402EA4CF-C642-4F11-B641-BD9BBFBD28DF Q34203916-5C062A5F-E07B-43A5-8125-AD9579E51D48 Q34203953-C28FC875-955D-470F-9207-BC5B27B0BA5D Q34203974-AAF7885E-36B4-4C4D-B9A1-18B026CA6C17 Q34331320-CB505828-831D-481B-97AA-0F6B7BDFA437 Q35004672-FC435715-8743-488D-8205-1857B545F2D1 Q35169154-3032B188-F82C-428B-BFFE-157891E54F60 Q35289895-72CF7E02-45F2-400A-8FB3-8435E27A3636 Q35914535-49D86165-C72E-43F8-A173-C830DF04190F Q35914767-7A952B1B-6E9F-45DC-86D2-B04E00CB10EA Q36292996-10F0C014-97D4-4B2E-A5FD-B30B16000CDB Q36339657-6B88A649-916B-4158-9420-42AC75977EAD Q36663825-F63E2250-9E4C-4369-A3D7-7B16900A6D95 Q36713514-2BE41DD9-381F-4253-9E21-51E080328C36 Q36764876-4A23DDE9-67B0-492C-B456-0BCC3065A9B2 Q36914450-16C242DD-B227-443A-9502-A8A4CFF7DE88 Q36943907-D22E6602-3BB9-4696-BF77-3D5B024B7DA4 Q37083986-07F42793-162B-4402-98EC-C9A5D1070F7D Q37170295-E6D53A8E-DC88-42A0-868E-788D69A182DF Q37354846-A442B41C-164B-4162-80F0-9CD43D4B86D9 Q37839482-484270C6-876B-479E-AD8F-F1949030CEAB Q38467345-03653EE6-F35D-46AA-B1F4-8171B6C7C966 Q38855020-80920FCA-EE48-4210-8025-002BA52479FD

P2860

Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.

http://www.wikidata.org/entity/Q35800552

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Comparison of linear and volum ...... e in adult high-grade gliomas.

@ast

Comparison of linear and volum ...... e in adult high-grade gliomas.

@en

type

label

Comparison of linear and volum ...... e in adult high-grade gliomas.

@ast

Comparison of linear and volum ...... e in adult high-grade gliomas.

@en

prefLabel

Comparison of linear and volum ...... e in adult high-grade gliomas.

@ast

Comparison of linear and volum ...... e in adult high-grade gliomas.

@en

P1433

Q35800552-20D1A857-F1F3-4089-9DF3-616A98444D49

P1476

Q35800552-38956193-4627-425B-A774-2C71F1138061

P2093

Q35800552-1E8315CB-35A9-4818-A263-241AF81BA47C

Q35800552-30185446-A40C-49D1-A717-A02F958E1BA0

Q35800552-50E63765-A60A-46CB-8C3C-819D8C0CCB5C

Q35800552-67918A68-D482-4315-A944-E8D6D67715E2

Q35800552-91E8207E-7C95-4CD2-96D5-88C0F5C0389A

Q35800552-A8B24E80-8BDD-449E-936F-C72E48D523CF

Q35800552-CB81CD3D-6BD1-4B79-86EB-7B42664D0506

Q35800552-E01B9B8C-E0C6-4BB6-9BF8-742D8935E7A0

Q35800552-EA9264EB-DC83-4F8D-834A-C2E6D6DFFF85

P2860

Q35800552-055F3F48-C340-4A52-AE22-E241C96B5812

Q35800552-1E75E8F7-3971-4D2B-91FE-7C67F6FC217A

Q35800552-34EC23AB-BE09-44CD-8587-B30862CEC81F

Q35800552-570A20D6-44E3-40C0-9ABE-9F33A910F64B

Q35800552-5B1214E2-BB17-4FF4-A0F2-5234B9A838E9

Q35800552-64EB06B5-C203-4A29-B6BE-0AFC0E33256E

Q35800552-6C2E8E3E-6E08-40FF-A240-337E1DCAD658

Q35800552-76CA4EE6-7CCA-4DE5-B340-8A29F7724C0B

Q35800552-7A64D6C1-8C32-4D6D-B15C-BBA0257F7F31

Q35800552-81E2BF3C-E21F-4125-A62F-D563CA71D4B8

P304

Q35800552-F2DFD8E6-A8F1-42D6-9784-32B6900C4728

P31

Q35800552-1A456C27-0A00-4E7C-B8D2-2D10AA8F49DC

P356

Q35800552-213795D5-9C78-41CC-9115-E590ADF0F9AA

P433

Q35800552-4476DFA4-D53C-49F5-B8AC-955D5A1C502B

P478

Q35800552-DDE88DC8-4B7C-4AEB-A699-C6F4D164874B

P577

Q35800552-E9CEEFDF-1560-4982-B899-E504E90DF3E9

P698

Q35800552-1C14FFD3-2E69-454E-8852-7C6B63F9534F

P932

Q35800552-E942F277-93A4-4482-8C4B-9B9242475070

P356

S1522851705000529

P1433

P1476

Comparison of linear and volum ...... e in adult high-grade gliomas.

@en

P2093

Alison M O'Neill

http://www.w3.org/2001/XMLSchema#string

Brenda Levy

http://www.w3.org/2001/XMLSchema#string

Fred H Hochberg

http://www.w3.org/2001/XMLSchema#string

Gaurav D Shah

http://www.w3.org/2001/XMLSchema#string

Joanna Bradshaw

http://www.w3.org/2001/XMLSchema#string

Patrick Y Wen

http://www.w3.org/2001/XMLSchema#string

Ronghui Xu

http://www.w3.org/2001/XMLSchema#string

Santosh Kesari

http://www.w3.org/2001/XMLSchema#string

Tracy T Batchelor

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Reporting results of cancer treatment

Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors.

Stereotactic radiosurgery associated neurotoxicity.

Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors.

Comparison of diameter and perimeter methods for tumor volume calculation.

Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers.

Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.

Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11.

Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.

P304

38-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1215/S1522851705000529

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16443946

http://www.w3.org/2001/XMLSchema#string

P932

1871928

http://www.w3.org/2001/XMLSchema#string